Nina Laue/LinkedIn
Jul 10, 2026, 02:32
Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
Nina Laue, Squad Lead Non-Malignant Hematology at Roche, shared a post on LinkedIn:
“Can you ever have too much science… or too many croissants?
Looking forward to joining the 34th ISTH Congress in Paris from July 11–15! #ISTH2026 is a fantastic opportunity to connect with colleagues from around the world, share ideas, and learn from the latest advances in haemostasis and thrombosis.
I’m also looking forward to refreshing my French and seeing whether my willpower is stronger than the city’s incredible pâtisseries.
See you in Paris!”
Stay Updated with ISTH 2026 on Hemostasis Today.
-
Aug 13, 2026, 11:05Khaled Musallam: The Evolving Landscape of β-Thalassemia: Clinical Trial Advances Since 2021
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
-
Aug 13, 2026, 08:11Cristiana Coneru: How the Gut Microbiome Influences Venous Thrombosis